Security key
39868T105
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS)
CUSIP: 39868T105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 160,529,963
- Total 13F shares
- 39,212,556
- Share change
- -7,682,521
- Total reported value
- $24,236,603
- Put/Call ratio
- 12%
- Price per share
- $0.62
- Number of holders
- 75
- Value change
- -$19,716,392
- Number of buys
- 36
- Number of sells
- 57
Report period
Q2 2024
Institutions
75
Top holders
10
GRTS full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Gritstone bio, Inc. SEC filings
Gritstone bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 39868T105
Recent filing periods:
Top shareholders of GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
4.2%
|
6,741,890
|
$17,326,657 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.6%
|
5,789,668
|
$14,879,448 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
3.6%
|
5,755,075
|
$14,790,543 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
4,733,791
|
$12,165,843 | — | 31 Mar 2024 | |
| Versant Venture Management, LLC |
13F
|
Company |
2.2%
|
3,561,150
|
$9,152,156 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.9%
|
3,074,867
|
$7,902,408 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.9%
|
2,980,015
|
$7,658,639 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,987,792
|
$5,109,193 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,800,275
|
$4,626,707 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.91%
|
1,467,880
|
$3,772,452 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.65%
|
1,043,903
|
$2,682,832 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.64%
|
1,030,952
|
$2,649,547 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.64%
|
1,030,878
|
$2,649,356 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.47%
|
754,463
|
$1,938,969 | — | 31 Mar 2024 | |
| Andrew R. Allen |
3/4/5
|
PRESIDENT AND CEO, Director |
—
mixed-class rows
|
3,049,635
mixed-class rows
|
$1,821,838 | — | 24 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
476,798
|
$1,225,371 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
340,478
|
$875,029 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.21%
|
331,079
|
$850,873 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
316,861
|
$814,332 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.18%
|
286,600
|
$736,563 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
267,205
|
$686,717 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
263,900
|
$678,223 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.15%
|
247,607
|
$636,350 | — | 31 Mar 2024 | |
| Karin Jooss |
3/4/5
|
EVP, Head of Research and Development |
—
mixed-class rows
|
918,526
mixed-class rows
|
$511,483 | — | 15 May 2024 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
182,998
|
$470,305 | — | 31 Mar 2024 | |
| Roman Yelensky |
3/4/5
|
Executive Vice President and Chief Technology Officer |
—
class O/S missing
|
234,672
|
$446,440 | — | 08 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
164,193
|
$421,976 | — | 31 Mar 2024 | |
| IRONWOOD INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.1%
|
157,603
|
$405,040 | — | 31 Mar 2024 | |
| Forum Financial Management, LP |
13F
|
Company |
0.1%
|
153,237
|
$393,820 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
148,530
|
$381,722 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
127,577
|
$327,873 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
127,423
|
$327,470 | — | 31 Mar 2024 | |
| Erin Jones |
3/4/5
|
EVP, CHIEF OPERATING OFFICER |
—
mixed-class rows
|
594,293
mixed-class rows
|
$268,859 | — | 15 May 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
100,317
|
$257,815 | — | 31 Mar 2024 | |
| Artia Global Partners LP |
13F
|
Company |
0.06%
|
95,170
|
$244,587 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
93,736
|
$240,902 | — | 31 Mar 2024 | |
| Matthew Hawryluk |
3/4/5
|
EVP, CHIEF BUSINESS OFFICER |
—
mixed-class rows
|
493,931
mixed-class rows
|
$234,915 | — | 15 May 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
86,827
|
$224,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
85,339
|
$219,321 | — | 31 Mar 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.05%
|
76,811
|
$197,404 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
57,751
|
$148,420 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.03%
|
55,033
|
$141,435 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.03%
|
46,237
|
$118,829 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.03%
|
44,431
|
$114,188 | — | 31 Mar 2024 | |
| Rahsaan W. Thompson |
3/4/5
|
EVP and General Counsel |
—
mixed-class rows
|
174,138
mixed-class rows
|
$111,667 | — | 31 Jan 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
41,098
|
$105,622 | — | 31 Mar 2024 | |
| TWIN PEAKS WEALTH ADVISORS, LLC |
13F
|
Company |
0.03%
|
40,314
|
$103,607 | — | 31 Mar 2024 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.02%
|
38,606
|
$99,217 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
36,780
|
$94,525 | — | 31 Mar 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
36,275
|
$93,227 | — | 31 Mar 2024 |
Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2024
As of 30 Jun 2024,
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,212,556 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, MORGAN STANLEY, Versant Venture Management, LLC, Alyeska Investment Group, L.P., DEUTSCHE BANK AG\, Artal Group S.A., FMR LLC, GOLDMAN SACHS GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
84
Q2 2024 holders
75
Holder diff
-9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.